ARCHIVES

Pathology Review Confirms Reserpine As Carcinogen

This article is from The Cancer Letter archive.

Vol. 06 No. 11 | March 14, 1980

Download PDF Visit The Full Archive

Related Articles

NCI Outlines Plan for Marin County Breast Cancer Review

November 22, 2002

Bush Appoints Lander To NCAB

January 24, 2003

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget.

January 14, 2005

St. Vincent Of NYC Joins Funded CCOPS Spurr To Be Professor Emeritus; UCOG, Still Unfunded, Still Active

May 1, 1987

ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections

January 6, 2012